Solventum
Preis: 79.22Unternehmen und Geschäftsmodell
Solventum operates in the healthcare sector, focusing on the development and commercialization of innovative medical solutions. Its core products include advanced therapeutic devices and diagnostic tools aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers and institutions. Solventum's business segments encompass research and development, manufacturing, and distribution of healthcare technologies.
Anlageprofil
The investment profile of Solventum is more aligned with growth investors, given its focus on innovation and potential for revenue expansion. The company shows stable earnings growth and a moderate risk profile, appealing to those seeking capital appreciation. Its performance metrics suggest a favorable outlook for long-term investment strategies.
Fundamentale Kennzahlen (experimentell)
- EPS (TTM) — Gewinn pro Aktie der letzten 12 Monate, $
- 8.21 OK
- Umsatz QoQ — Umsatzwachstum im Quartalsvergleich
- 0.5% ≈
- EPS-Überraschung
- 9.6% besser als erwartet
- 20d Volatilität
- 2.1% stabil
Prognoseauswirkung
ausgespieltIm Portfolio verfolgen
Preischart
| Datum | Vorher | Nachher | Grund |
|---|---|---|---|
| 2026-06-10 00:49 | Halten | Kaufen | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-06-09 02:51 | Kaufen | Halten | Mixed performance and uncertain market conditions. |
| 2026-06-05 02:48 | Halten | Kaufen | Strong momentum and solid EPS growth support bullish outlook. |
| Datum | Analyst | Action | Ziel | Preis damals |
|---|---|---|---|---|
| 2026-06-01 11:15 | Jefferies | Ziel erhöht | — → 43 | 74.95 |
| 2026-05-15 11:13 | Wedbush | Aktualisieren | — → 94 | 74.42 |
| 2026-05-06 13:34 | UBS | Ziel gesenkt | 82 → 78 | 71.355 |
Noch nichts